Search filters

List of works by Vilija Jokubaitis

A genetic basis for multiple sclerosis severity: Red herring or real?

scientific article published on 18 August 2016

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.

scientific article published on 9 August 2017

Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation

scientific article

Ceruloplasmin gene-deficient mice with experimental autoimmune encephalomyelitis show attenuated early disease evolution.

scientific article

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.

scientific article

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

scientific article published on 5 December 2014

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

scientific article published on April 2016

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

scientific article published on 13 January 2019

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

scientific article published on April 2015

Contribution of different relapse phenotypes to disability in multiple sclerosis.

scientific article published on 7 April 2016

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

scientific article

Defining reliable disability outcomes in multiple sclerosis

scientific article published on 10 September 2015

Defining secondary progressive multiple sclerosis

scientific article published on 7 July 2016

Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis

scientific article published on 09 July 2013

Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor

scientific article published on 29 January 2015

Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.

scientific article published on May 2008

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

scientific article published on 28 September 2016

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

scientific article published on 03 January 2019

Increasing age at disability milestones among MS patients in the MSBase Registry

scientific article published on 14 April 2012

Leukemia inhibitory factor protects axons in experimental autoimmune encephalomyelitis via an oligodendrocyte-independent mechanism

scientific article

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

scientific article published on April 2017

Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells

scientific article published on 09 June 2020

Predictors of disability worsening in clinically isolated syndrome.

scientific article published on 27 March 2015

Predictors of long-term disability accrual in relapse-onset multiple sclerosis

scientific article published on 4 May 2016

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.

scientific article published on 24 November 2016

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study

scientific article

Risk of relapse phenotype recurrence in multiple sclerosis.

scientific article

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

scientific article published on 18 October 2013

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.

scientific article published on 17 January 2015

The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform

scientific article

The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

scientific article published on 21 July 2015

The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude

scientific article published on 20 December 2011

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

scientific article published in September 2017

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

scientific article published on 10 February 2017

Paulina is supported by:

About Paulina

Help